B Group, Inc. Q4 2024 Filing
Filed February 14, 2025
Portfolio Value
$163.6B
Holdings
18
Report Date
Q4 2024
Filing Type
13F-HR
All Holdings (18 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | QQQINVESCO QQQ TR | 110,000 | $56.2B | 34.37% | |
| 2 | ADMAADMA BIOLOGICS INC | 2,287,542 | $39.2B | 23.98% | |
| 3 | IM8NINSMED INC | 350,000 | $24.2B | 14.77% | |
| 4 | ZLABZAI LAB LTD | 400,000 | $10.5B | 6.40% | |
| 5 | IOVAIOVANCE BIOTHERAPEUTICS INC | 992,000 | $7.3B | 4.49% | |
| 6 | AKROAKERO THERAPEUTICS INC | 260,000 | $7.2B | 4.42% | |
| 7 | CLLSCELLECTIS S A | 3,081,501 | $5.5B | 3.39% | |
| 8 | AURAAURA BIOSCIENCES INC | 472,576 | $3.9B | 2.37% | |
| 9 | SGHTSIGHT SCIENCES INC | 629,370 | $2.3B | 1.40% | |
| 10 | TSHATAYSHA GENE THERAPIES INC | 965,556 | $1.7B | 1.02% | |
| 11 | RAREULTRAGENYX PHARMACEUTICAL IN | 29,500 | $1.2B | 0.76% | |
| 12 | SYRESPYRE THERAPEUTICS INC | 50,000 | $1.2B | 0.71% | |
| 13 | ASMBASSEMBLY BIOSCIENCES INC | 50,651 | $799.3M | 0.49% | |
| 14 | APGEAPOGEE THERAPEUTICS INC | 15,000 | $679.5M | 0.42% | |
| 15 | CRVSCORVUS PHARMACEUTICALS INC | 100,000 | $535.0M | 0.33% | |
| 16 | BNTXBIONTECH SE | 3,500 | $398.8M | 0.24% | |
| 17 | ORKAORUKA THERAPEUTICS INC | 20,000 | $387.8M | 0.24% | |
| 18 | RAREULTRAGENYX PHARMACEUTICAL IN | 7,596 | $319.6M | 0.20% |